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Abstract  
This study utilized 2D-DIGE, isotope-coded protein labelling (ICPL) and biochemical assays to characterize 
protein alteration in Ulcerative Colitis (UC) and Crohn’s Disease (CD) in human epithelial cell and mucosal 
biopsies in Inflammatory Bowel Disease (IBD)-affected patients. The aim of this study is to identify the key 
molecular signatures involved in epithelial cell structure of IBDs.  
In non-inflamed UC (QUC) keratins, vimentin and FAK increased, whereas vinculin and de-tyrosinated α-
tubulin decreased; inflammation (IUC) exacerbated molecular changes, being COL6A1, tenascin-C and 
vimentin increased. In non-inflamed CD (QCD) TNC, de-tyrosinated α-tubulin, vinculin, FAK and ROCK1 
decreased while vimentin increased; in inflamed CD (ICD) COL6A1 and vimentin increased. In QUC, cell 
metabolism was characterized by a decrease of the TCA cycle enzymes and a decrease of ACADSB, FASN, 
pparα and pparγ. In QCD a metabolic rewiring occurred, as suggested by GPD2, PDHB, NDUFS3 and 
ALDH9A1 increment, while DLD decreased. Macroautophagy was activated in QUC and IUC, with 
increased levels of p62, HSC70, MVP, MYH9, whereas it was blunted in QCD and ICD. 
The differing pattern of ECM, cytoskeletal derangements, cellular metabolism and autophagy in UC and CD 
may contribute to the pathophysiological understanding of these disorders and serve as diagnostic markers in 
IBD patients.  
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Statement of significance of the study  
The identification of potential disease molecular signatures in UC and CD help shed light onto these 
complex disorders, highlighting new molecules, at cytoskeletal, metabolic and cell renewal level, which 
have never been described before in IBD. The study provides clear indication on the cytoskeletal 
rearrangement taking place in UC with the contribution of ECM and microenvironment to cell signalling 
from outside to inside the epithelial cell. Inflammation exacerbates this rearrangement, modifying membrane 
stiffness and favouring leucocytes homing. For the first time in IBD, the authors have described the 
increment of a specific enzyme involved in isoleucine catabolism with activity towards the degradation of 
branched-chain fatty acids (HSD17B10) that contribute to cell homeostasis and make cells able to support 
energy requirements by promoting the activation of the mTOR signalling. Another original observation is 
that in UC, macroautophagy is sustained by over-expression of p62, MVP and MYH9.  
Concerning CD, its severity is highlighted by the absence of autophagy and cell renewal, whereas a 
metabolic rewiring to sustain cell metabolism occurred. Another unique aspect is the increase of vimentin, 
which can promote, together with impaired autophagy and an increase in COLVI, myofibroblasts 
transformation leading to fibrosis, a condition that characterises CD patients. 
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1 Introduction 
Inflammatory bowel diseases (IBD) are chronic and relapsing inflammatory conditions of the 
gastrointestinal tract. They comprise Crohn’s Disease (CD) and Ulcerative Colitis (UC). Both CD and UC 
are characterized by a persistent inflammation that disrupts both the structure and functioning of the 
gastrointestinal mucosa. The aetiology and exact pathogenic mechanisms of IBD are unknown, however 
much interest has recently focused on an aberrant immune-inflammatory response to intestinal microbiota in 
genetically predisposed individuals. An important role in the interaction between microbiota and external 
antigens with our organism is attributed to the intestinal epithelium, which is no longer identified as a mere 
effector of absorptive and secretory activities but is recognized as an immunologically active cell population 
as well as a critical barrier to the penetration of threatening external factors. Normally, the intestinal 
epithelium is covered by a single layer of intestinal epithelial cells (IECs), which are characterised by a fast 
renewal rate, and it acts as a protective barrier against luminal antigens. Cells are linked by intercellular tight 
junctions, located at the apical ends of the lateral membrane, and they are coated by a thick adherent mucus 
gel, which forms a dynamic physical interface [1]. This barrier represents the largest area of contact between 
the inside of our body and the external environment and it is surrounded by many inflammatory cell types. 
Despite its robust and multi-faceted nature, this barrier can be damaged, thus promoting a state of chronic 
inflammation due to mucosal immune cell infiltration, as is typically observed in IBD patients [2]. Indeed, at 
least for UC, the important role of intestinal epithelial dysfunction has been suggested and the possible role 
of intestinal epithelium-derived antigens as the autoantigen has been proposed [3]. More recently, several 
genome-wide association studies (GWAS) have identified the intestinal epithelium as an important actor in 
the pathogenesis of IBD, indicating several genes related to the epithelial structure. The mechanism of 
autophagy may also be a possible contributor to IBD predisposition [4, 5]. Indeed, the presence of specific 
polymorphisms in the following genes has been shown to be associated with the development of IBD: 
Nucleotide- binding oligomerisation domain-containing protein2 (NOD2) [6, 7], Autophagy-related protein 
16-like 1 (ATG16L1) [8], Unc-51 like autophagy activating kinase 1 (ULK1) [9], Extracellular matrix 
protein 1 (ECM1), Tubulin polymerization-promoting protein (TPP1), Collagen Type VII Alpha 1 Chain 
(COL7A1) [10], ADAM Metallopeptidase Domain 17 (ADAM17) [11] and Fermitin Family Member 1 
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(FERMT1) [12].   
The typical activation of the inflammatory pathways and the consequent unbalance between pro- and anti-
inflammatory cytokines and mediators have been discussed in IBD for a long time; on the other hand, 
molecular changes of the epithelial tissue, including extracellular matrix and junction proteins in both 
inflamed and non-inflamed regions of the intestinal tract in IBD, have only partially been addressed. Thus, it 
appears that studies focusing on intestinal epithelium are warranted. In this respect, the classic proteomic 
approach has been frequently fruitful in the study of several other diseases of unknown aetiology and of 
possible immune-mediated pathogenesis. Thus far, proteomic studies on IBD patients have been mainly 
focused on the effects of inflammation rather than on the understanding of molecular mechanisms leading to 
disease onset or disease exacerbation. Overall, these studies have provided hints on the association of 
inflammation, energy metabolism and oxidative stress as possible driving forces for disease onset and 
exacerbation [13-17].    
Recent independent studies by our group have highlighted the relationship between ECM dysregulation 
caused by Collagen VI deficiency and signal transmission from outside to inside the muscle cell. This 
signalling impacts on mitochondrial homeostasis and autophagy leading to muscle lipotoxicity [18, 19]. In 
the present paper, in order to address the above issues on intestinal epithelial cells from IBD patients, an 
unbiased “omics” approach was carried out to possibly unravel the physiopathological mechanisms that may 
be involved in intestinal epithelial cells homeostasis disruption in UC and CD patients and to detect selective 
changes that are able to differentiate between CD and UC.  
2 Materials and methods 
2.1 Sample collection 
2.1.1 Ethics statement 
The Internal Review Board of the local Ethical Committee approved the study (Ethical Committee Protocol 
number n. 2726, ASL Milano-2, approved on October 2
nd
 2012), in accordance with the 1964 Declaration of 
Helsinki.  
2.1.2 Patients 
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Colonic surgical specimens and non-inflammatory controls were obtained from either UC- or CD-affected 
male and female patients, aged 21 to 82 years, who were admitted to the IRCCS Policlinico San Donato 
(San Donato Milanese, Italy) and who underwent therapeutic bowel resection for IBD or for malignant and 
other non-malignant non-inflammatory conditions. Full-thickness colonic tissues were used as a source for 
the mucosal IEC. In patients who underwent surgical resection for colonic neoplasia, the part of surgical 
specimen that was collected and used for IEC isolation was macroscopically normal and was the most 
distant from the neoplasia. 
Colonic endoscopic biopsies and controls were harvested from male and female patients affected by CD or 
UC, aged 25-70 years, who underwent colonoscopy for diagnostic or surveillance purposes at the IRCCS 
Policlinico San Donato; these were used for protein extraction. 
2.1.3 Isolation of Intestinal Epithelial Cells from surgical specimens 
Colonic surgical specimens were collected and processed immediately after surgical resection, as previously 
described [20]. Briefly, specimens were opened longitudinally, rinsed and examined for macroscopic 
morphological alterations, and representative full-thickness samples were obtained. Intestinal mucosa was 
stripped from the muscularis mucosa, cut into strips and washed in Hank's Balanced Salt Solution (HBSS; 
Invitrogen/GIBCO) containing 10 mM DTT (Sigma-Aldrich) in order to remove mucus. IEC were isolated 
by repeated incubations in HBSS containing 1 mM EDTA (Sigma-Aldrich). A 40% Percoll Plus gradient 
(GE Healthcare), where the IEC was equilibrated at the interface, was used in order to remove mononuclear, 
red blood and dead cells; resulting preparations enriched for IEC were collected and washed twice in PBS, 
and subsequently counted. Cell preparations were stained by means of an immunoperoxidase method, with 
an anti-keratin mAb and a monoclonal antibody directed against a leukocyte common Ag (CD45), resulting 
in a <1% contamination of epithelial cell preparations by LPMC.  
2.2 Proteomic analysis 
Intestinal epithelial cell extracts from surgical specimens were obtained from patients with inflamed UC and 
CD (IUC, ICD; n=10) and patients with non-inflamed UC and CD (QUC, QCD; n=10) and from normal 
pathological specimens obtained from individuals without IBD (control, C; n=10); these were analysed by 
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2D-DIGE, isotope-coded protein labeling (ICPL) and immunoblot assay to evaluate proteome changes in 
inflamed and non-inflamed UC and CD patients compared to healthy controls. 
Confirmatory blots were performed on biopsy specimens from inflamed and non-inflamed colonic mucosa 
obtained during colonoscopy by means of endoscopic biopsies from IUC, QUC, ICD and QCD patients 
(n=5/experimental group) and controls (n=6).  
2.2.1 Protein extraction 
For 2D-DIGE and immunoblot assays, each sample from each subject was suspended in lysis buffer (7 M 
urea, 2 M thiourea, 4% CHAPS, 30 mM Tris, and 1 mM PMSF) and solubilized by sonication on ice. 
Proteins were selectively precipitated using PlusOne 2D-Clean up Kit (GE Healthcare, Little Chalfont, UK) 
in order to remove non-protein impurities, and they were re-suspended in lysis buffer. The pH of the protein 
extracts was adjusted to pH 8.5 by addition of 1 M NaOH. Protein concentrations were determined by 
PlusOne 2D-Quant Kit (GE Healthcare). 
2.2.2 2D-DIGE 
Intestinal epithelial cells extracts were analysed by quantitative 2D-DIGE, followed by mass spectrometry. 
The 2D-DIGE method was inserted in a MIAPE-GE compliant form [21] in Supporting Information Table 
1S. Protein minimal labelling with cyanine dyes (Cy3 and Cy5), 2D separation and analyses were performed 
as described previously [22]. Briefly, the proteins extracted (50 µg) from each individual sample were 
labelled with Cy5, while internal standards were generated by pooling (50 µg) individual samples that were 
Cy3-labeled. Samples were separated on 3–10 nonlinear immobilized pH gradient (IPG) strips; each 
individual sample was run in triplicate (analytical replicates) to minimize the inter-gel variability and 
increase the reliability of the results. Image analysis was performed using DeCyder 6.5 software (GE 
Healthcare). All gel images were imported into individual differential in-gel analysis (DIA) workspaces. 
Using the Batch Processor tool, automated detection of protein spots was performed with the following filter 
settings: estimated number of spots=10000, exclusion slope>1.2; minimal area cutoff<200, and peak 
height=100000. DIA workspaces were then manually edited to eliminate gel artefacts (e.g., plate scratches 
and dust specks) and include any incorrectly excluded spot. The resulting spot maps (containing the spot 
identifiers, locations and normalized volumes for all protein spots in each channel of each gel) were further 
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processed in the biological variation analysis (BVA) module. Individual DIA workspaces for all analytical 
gels were imported into the BVA module. The BVA workspace was used for inter-gel protein spot 
matching. Statistical analysis was performed using the DeCyder 1.0 extended data analysis (EDA) module. 
Protein filters were set to select only those protein spots that matched 90% of the gel images and these 
protein spots were included in data analysis. For proteomic experiments, statistically significant differences 
were computed by independent one-way ANOVA, coupled to Turkey’s multiple group comparison test; the 
significance level was set at p<0.01. To minimize inclusion of false-positive protein spot changes, protein 
expression data were filtered using the following criteria: independent one-way ANOVA, coupled to 
Turkey’s multiple group comparison test (p<0.01), 1.15-fold difference in abundance, and false discovery 
rate (FDR). The change of 1.15-fold and above in protein abundance was adopted for the present analysis, 
taking into account the power of the DIGE method to detect reliable differences in protein abundance down 
to 15% [23, 24]. FDR correction was applied as a multiple testing correction method to keep the overall 
error rate as low as possible [25]. Proteins of interest were identified by mass spectrometry. 
2.2.3 Protein identification by MALDI-TOF MS 
Semipreparative gels, containing 400 µg of total protein extract per strip, were loaded; electrophoretic 
conditions were the same as for 2D-DIGE, except that gels were stained with a protein fluorescent stain 
(Deep Purple Total Protein Stain, GE Healthcare). Image acquisition was performed using the Typhoon 
9200 laser scanner. Proteins were identified by PMF utilizing a MALDI-ToF mass spectrometer (Ultraflex 
III ToF/ToF; Bruker Daltonics, Bremen, Germany), as previously described [26]. In particular, the search 
was performed by correlation of uninterpreted spectra to Homo sapiens entries in NCBInr database 
20100918 (11833178 sequences; 4040378175 residues). Protein identification methods are provided in a 
MIAPE-MS compliant form [21] in Supporting Information Table 1S. (For further information about protein 
identification, see Supporting Information Table 2S and Supporting Information Figure 1S). 
2.2.4 ICPL 
Intestinal epithelial cell extracts obtained from QUC, QCD and C were analysed by differential proteomics 
based on ICPL. A total of 100 µg of proteins per sample were purified using the PlusOne 2D-Clean up Kit 
(GE Healthcare) and protein pellets were then dissolved in 6 M guanidine HCl, pH 8.5. Protein 
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concentration was determined using the PlusOne 2D-Quant Kit (GE Healthcare) and adjusted to 5-10 µg/µL 
in all samples. ICPL labelling of proteins was performed according to the manufacturer’s instructions using 
the SERVA ICPL
TM
 Quadruplex PLUS Kit (Serva, Heidelberg, Germany). C, QUC and QCD were labelled 
using light ICPL_0, heavy ICPL_6 and ICPL_10 labeled reagents, respectively. The three labeled samples 
were then combined and the proteins were purified by acetone precipitation at −20°C overnight. The mixture 
was centrifuged at 20000 × g for 30 min at +4°C. The supernatant was discarded and remaining acetone was 
removed by evaporation at RT. The protein pellet was then dissolved in 50 mM ammonium bicarbonate and 
RapiGest SF surfactant (Waters Corporation) and protein concentration was determined using the PlusOne 
2D-Quant Kit. Reduction and alkylation were performed after adjusting the pH of each sample to 8.5, and 
using DTT (incubation at 60°C for 30 min) and iodoacetamide (incubation at RT in the dark for 30 min), 
respectively. Finally, proteins were digested using trypsin at an enzyme/substrate ratio of 1:50 overnight at 
37°C. Digestion was stopped by formic acid 0.1% (v/v, final concentration). The resulting peptides were 
separated by reverse phase chromatography (75 µm id x15cm PepMap column, Thermo Fisher Scientific) 
using the nano-HPLC EASY-nLC (Bruker Daltonics) through a linear gradient of 85 minutes from 5 % B to 
60 % B (solvent A: water/0.05 % TFA, solvent B: 90% ACN/9.95% water/0.05% TFA) with a flow of 300 
nL/min. The n-LC was coupled with the high-resolution mass spectrometer MaXis hybrid UHR-QToF 
(Bruker Daltonics) for protein identification. Protein quantification was performed on the basis of peptides, 
by using Warp-LC v. 1.2 (Bruker Daltonics). The extracted ion chromatograms (EICs) were calculated by 
using the m/z values of identified peptides and summing the intensities of the mass peaks (mass tolerance of 
0.5 Da). A retention time window was fixed at 0.4 min around the elution time of the identified peptides, and 
only charge states +2, +3 and +4 were taken into account when the EIC was generated. The chromatographic 
peak finder in Data Analysis (Bruker Daltonics) was adopted to detect peaks, and only peptides with an ion 
score above 20 were used to quantify protein species. The areas under the curve were calculated by Data 
Analysis chromatographic peak finder; of the first three peaks of the isotopic distribution were summed for 
both the heavy and light components of an isotopic pair. The regulation ratio was calculated using the 
summed intensities. For statistical analysis, all data were converted in the log space to maintain symmetry 
around zero. The global mean and SD of protein ratios were calculated for each couple of the sample. The 
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cut-off point for protein differential abundance was determined as the mean ± 2SD (95% confidence 
interval) and protein differential abundance was assessed using the Student's t-test. (For further information 
about protein identification, see Supporting Information Table 3S) 
2.2.5 2D-DIGE and ICPL orthogonal validation by immunoblotting 
The 2D-DIGE and ICPL results were validated performing a random analysis via immunoblotting of 16% of 
the identified proteins (Supporting Information Figure 2). Protein extracts (50 µg) from pooled samples were 
loaded in triplicate and resolved on 6–14% polyacrylamide gels. Blots were incubated with rabbit, mouse or 
goat polyclonal primary antibodies as follows: anti-keratin type I cytoskeletal 19 (KRT19; GeneTex, CA, 
USA), 1:3000; anti-tubulin beta-2C chain (TUBB4B; Sigma Aldrich, USA), 1:1000; anti-succinate 
dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (SDHA; Santa CruzBiotechnology, CA, 
USA), 1:1000; anti-galectin-3 (LGALS3; Abnova, Taipei City, Taiwan), 1:5000; anti-prohibitin (PHB, 
GeneTex), 1:5000; anti-keratin type I cytoskeletal 18 (KRT18; Cell Signaling Technology, Danvers, MA, 
USA), 1:2000; anti-heat shock cognate 71 kDa protein (HSC70; Cell Signaling Technology), 1:1000; anti-
78 kDa glucose-regulated protein (GRP78; Santa Cruz Biotechnology), 1:500.  
After washing, membranes were incubated with anti-rabbit or anti-mouse (GE Healthcare, Milan, Italy) or 
anti-goat (Santa Cruz Biotechnology) secondary antibodies, conjugated with horseradish peroxidase. Signals 
were visualized by chemiluminescence using the ECL Prime detection kit (GE Healthcare). Image analysis 
(Image Quant TL, Molecular Dynamics, Ragusa, Italy) was performed, followed by statistical analysis 
(Student’s t-test, p < 0.05). Data were normalized against the total amount of loaded proteins stained with 
Sypro Ruby Blot Stain (Life Technologies Europe BV, Monza, Italy). 
2.3 Protein quantitation by immunoblotting 
Immunoblotting procedures were as described above. Blots were incubated with rabbit, mouse or goat 
polyclonal primary antibodies (Santa Cruz Biotechnology, except when differently stated) as follows: anti-
collagen type VI alpha 1 chain (COL6A1), 1:200; anti-tenascin C (TNC), 1:1000; anti-integrin β7, 1:500; 
anti-integrin α4, 1:500; anti-focal adhesion kinase (FAK; Cell Signaling Technology), 1:1000; anti-Rho-
associated protein kinase 1 (ROCK1; Cell Signaling Technology), 1:1000; anti-vimentin, 1:1000; anti-
detyrosinated α-tubulin (de Tyr α-Tubulin; Abcam, Cambridge, UK), 1:500; anti-vinculin, 1:500; anti-citrate 
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synthase, 1:500; anti-fatty acid synthase (FASN), 1:100; anti-peroxisome proliferator-activated receptors 
gamma (pparγ), 1:500; anti-peroxisome proliferator-activated receptors alpha (pparα), 1:500; anti-heat shock 
cognate 71 kDa protein (HSC70), 1:1000; anti-myosin heavy chain 9 (MYH9), 1:500; anti-major vault 
protein (MVP); 1:2000; anti-ubiquitin-binding protein p62 (p62; Sigma Aldrich), 1:1000; anti-light chain 3B 
(LC3B; Cell Signaling Technology), 1:500; anti-bcl-2-like protein 4 (BAX), 1:1000; anti-beclin1, 1:1000; 
anti-B-cell lymphoma-extra large (Bcl-xL; Cell Signaling Technology), 1:1000; anti-BCL2/adenovirus E1B 
19 kDa protein-interacting protein 3 (Bnip3) 1:1000; B-cell leukemia/lymphoma 2 (Bcl-2; Cell Signaling 
Technology). 
3 Results 
3.1 Comparative proteomic analysis  
To unravel possible molecular processes involved in disease aetiology, intestinal epithelial cell extracts from 
UC, CD patients and controls were analysed by 2D-DIGE, ICPL LC MS/MS and immunoblot assay. 
3.1.1 2D-DIGE 
Intestinal epithelial cell extracts were analysed by 2D-DIGE to assess proteome changes in non-inflamed 
UC and CD patients, compared to controls. 
Concerning UC, epithelial cells were purified from surgical specimens from 10 patients with non-inflamed 
UC and 10 controls. Overall, 1000 spots were matched among gels and 22 spots were changed in abundance 
in QUC vs C. With regard to CD, epithelial cells obtained from patients with non-inflamed CD (n=10) and 
individuals without obvious inflammatory colonic disorder (n=10) were purified as previously described 
[20]. The proteomic analysis provided 27 spots changes in abundance in QCD vs C. A representative 2D 
map of intestinal epithelial cells, after cell extract separation in 3-10 non linear pH gradient IPG strips, is 
shown in Supporting Information Figure 3S. The entire list of proteins differentially expressed together with 
statistical analyses, protein accession number, gene name, theoretical molecular mass, isoelectric points and 
MS data are listed in Supporting Information Table 2S. The protein identification was validated performing 
a random analysis via immunoblotting of 16% of the identified proteins (see Supporting Information Figure 
2S). The identified proteins were then grouped according to their role.  
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The semiquantitative proteomic profile of QUC and QCD vs C (Figure 1) revealed a peculiar signature for 
UC and CD, in which changes of proteins involved in cytoskeleton organization, metabolism, stress and 
antioxidant response played a prominent role. 
Cytoskeletal dysregulation in QUC vs C was characterized by a decrease in keratin type II cytoskeletal 8 
(KRT8) [27], actin cytoplasmic 1 (ACTB), tubulin beta-2C chain (TUBB4B) and mitochondrial inner 
membrane protein (IMMT), whereas keratin type I cytoskeletal 19 (KRT19) increased. Several metabolic 
proteins were decreased, such as: succinate dehydrogenase [ubiquinone] flavoprotein subunit (SDHA), ATP 
synthase subunit beta (ATP5B) and short/branched chain specific acyl-CoA dehydrogenase (ACADSB). The 
latter catalyses the dehydrogenation of acyl-CoA derivatives and is involved in L-leucin catabolism. 
Conversely, there was an increase in 3-hydroxyacyl-CoA dehydrogenase type-2 (HSD17B10), which 
catalyses the oxidation of neuroactive steroids and represents the third step in the beta oxidation of fatty 
acids [28]. Among the proteins involved in stress response: 60 kDa heat shock protein (HSP60), preventing 
protein misfolding) and peroxiredoxin-2 (PRDX2) both decreased, whereas the protein disulfide-isomerase 
A3 (GRP58) was more abundant in QUC than in C. The Elongation factor tu (TUFM), which regulates 
protein synthesis, was down-regulated in QUC compared to controls. 
Conversely, QCD vs C was characterized by a down-regulation of KRT8 and keratin type I cytoskeletal 18 
(KRT18). Metabolic proteins of QCD vs C showed a down-regulation of dihydrolipoyl dehydrogenase 
(DLD), whereas the authors observed an up-regulation of glycerol-3-phosphate dehydrogenase (GPD2), 
pyruvate dehydrogenase E1 component subunit beta (PDHB), NADH dehydrogenase [ubiquinone] iron-
sulfur protein 3 (NDUFS3) and 4-trimethylaminobutyraldehyde dehydrogenase (ALDH9A1), involved in 
the pathway of carnitine and polyamine biosynthesis. Concerning stress response proteins: heat shock 
cognate 71 kDa protein (HSC70), which is involved in chaperone-mediated autophagy; heat shock 70 kDa 
protein 1A/1B (HSPA1A/B), which contributes to the homeostasis of the immune system by directly 
modulating the expansion and function of conventional T-cells; 78 kDa glucose-regulated protein (GRP78), 
GRP58 and PRDX2 were decreased, thus suggesting the activation of endothelial reticulum (ER) stress and 
unfolded protein response (UPR). Annexin A4 (ANXA4) and annexin A5 (ANXA5), which bind negatively 
charged phospholipids in a calcium dependent manner, were less abundant in QCD, compared to controls. 
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Voltage-dependent anion-selective channel protein 1 (VDAC1), the mitochondrial 28S ribosomal protein 
S22 (MRPS22), the endoplasmic reticulum lipid raft-associated protein 2 (ERLIN2), which mediates the 
endoplasmic reticulum-associated sterol degradation (ERAD), and the complement component 1 Q 
subcomponent-binding protein (C1QBP) involved in inflammation and infection processes, were up-
regulated in QCD. 
Both QUC and QCD compared to C were characterized by a down-regulation of prohibitin. The 
mitochondrial prohibitin complex controls cell proliferation, cristae morphogenesis and the functional 
integrity of mitochondria and inhibits DNA synthesis. Galectin-3 (LGALS3) and carbonic anhydrase 1 
(CA1) were also decreased. Conversely, the receptor of activated protein C kinase 1 (RACK1, shuttling 
proteins around the cell and anchoring proteins at particular locations stabilising protein activity) was up-
regulated, compared to controls [29]. 
3.1.2 ICPL 
To increase the data set of proteomic changes in UC and CD epithelial cell extracts, an ICPL analysis was 
performed (Figure 2). This quantitative proteomic approach allowed for the identification and quantification 
of 2648 peptides, corresponding to 1058 proteins. A stringent statistical analysis was applied to this set of 
identified proteins and only proteins identified by 5 peptides and common to all analysed samples were 
considered. Collectively, 19 proteins were dysregulated in QUC compared to controls, 18 increased and one 
decreased, whereas 5 were at variance in QCD vs C (2 increased and 3 decreased). The first observation is 
that the set of dysregulated proteins is different from the group recognized by 2D-DIGE, but few proteins 
were common to both proteomic analyses, confirming the relevance of these two independent proteomic 
approaches.  
QUC compared to C is characterized by increased levels of structural proteins like myosin-9 (MYH9), 
keratin type I cytoskeletal 10 (KRT10), keratin type I cytoskeletal 14 (KRT14), KRT18, tubulin alpha-
ubiquitous chain (TUBA1B) and vimentin (VIM). On the contrary, the corticosteroid 11-beta-
dehydrogenase isozyme 2 (HSD11B2), which is related to the transformation of cortisol into cortisone to 
counteract inflammation by increasing glucocorticoids, was significantly decreased. Proteins involved in 
transcription regulation and folding were also increased, particularly, the heterogeneous nuclear 
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ribonucleoprotein A1 (HNRPNA1), which is involved in the packaging of pre-mRNA into hnRNP particles 
and transport of poly(A) mRNA from the nucleus, and the major vault protein (MVP), which acts as 
scaffolds for proteins involved in signal transduction. A number of proteins playing a role in chromatin 
remodelling, like histone H2A type 2-A (HIST2H2AA 3), type 1-B (HIST1H2AB), type 1-C (HIST1H2AC), 
histone H3.1 (HIST1H3A) and histone H4 (HIST1H4A), which is a core components of the nucleosome, 
were increased. Proteins associated to protein folding and transport were increased, including: the splicing 
factor proline- and glutamine-rich (SFPQ), which is involved in transcriptional regulation and recruitment of 
histone deacetylases (HDACs); the heat shock protein 75 kDa (TRAP1), which is involved in maintaining 
mitochondrial function and polarization most likely through stabilization of mitochondrial complex I; the 
peptidyl-prolyl cis-trans isomerase B precursor (PPIB), which catalyses the transcription of DNA into RNA; 
the ribosome-binding protein 1 (RRBP1), which mediates the interaction between the ribosome and the 
endoplasmic reticulum membrane; and coatomer subunit alpha (COPA), which is a cytosolic protein 
complex essential for the retrograde Golgi-to-ER transport of dilysine-tagged proteins.    
Concerning QCD, this study confirmed a smaller and different spectrum of protein variations compared to 
QUC: sodium/potassium-transporting ATPase alpha-1 chain precursor (ATP1A1) and HIST1H3A increased, 
whereas MYH9, MVP and HIST1H2AC decreased in QCD compared to C.    
From the present proteomic data, protein variation suggests that at epithelial cell level the disease impacts 
differently on the proteome signature of UC and CD, though some features appear common. 
As a result, proteomic analysis offers a hint to decipher the pathophysiological mechanisms associated to 
diseases [18, 30], therefore further analysis to demonstrate the validity of proteomic data, not only through 
the validation of proteomic results by an independent technology but also assessing the impact of 
dysregulated protein on specific sub cellular compartments, could be relevant to gain better insight onto the 
pathophysiological mechanisms of these complex disorders.  
3.2 Protein quantitation by immunoblotting 
To further prove the role of cytoskeleton, metabolism and stress response dysregulations in the intestinal 
mucosa of UC and CD patients, quantitation of selected proteins and of some upstream regulators 
controlling their expression levels was evaluated by immunoblotting.  
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These experiments focused on those cellular metabolic/structural pathways that were identified by previous 
proteomic analyses (e.g. cytoskeleton rearrangement, metabolism and stress response). Interestingly, these 
pathways can significantly impact cell signalling from inside to outside the epithelial cell and vice-versa, 
leading to cell death and failure of cell renewal.  
In this experimental section, protein extracts from colonic endoscopic biopsies from inflamed and non-
inflamed regions of the gastrointestinal tract of UC and CD patients were analysed to explore the role of 
inflammation on the above-mentioned pathways in UC and CD. 
3.2.1 Cytoskeleton rearrangements: Stiffness and cell signal mechanotransduction 
Proteomic results indicated that the cytoskeletal components appear at variance in non-inflamed UC and CD 
compared to controls. In QUC versus controls, different proteoforms of KRT8, ACTB and TUBB4B were 
reduced, whereas KRT10, KRT14, KRT18, KRT19 and vimentin were increased. In QCD vs C, KRT8 and 
KRT18 were decreased. Collectively, these results suggest a possible remodelling of the cytoskeletal 
structure and an altered signal transmission from inside to outside or vice-versa of the epithelial barrier in 
UC, whereas in CD changes appear modest, further supporting the need for upstream regulators of the 
mechanical signal transduction from outside to inside the epithelia cell to understand mechanisms associated 
to epithelial damage.  
Figure 3 panel A and B shows the immunoblotting quantitative analysis of molecules involved in ECM 
molecular structure and signal mechanotransduction in QUC and IUC, compared to controls. With regards to 
QUC vs C, collagen VI alpha 1 chain (COL6A1) and tenascin C (TNC) were unchanged, whereas vinculin 
and detyrosinated α-tubulin (de Tyr α-Tubulin), localized on membrane surface, were reduced. Interestingly, 
focal adhesion kinase (FAK), which are the sensors inside the cell involved in cellular adhesion, and the 
structural protein vimentin were increased, whereas Rho-associated protein kinase 1 (ROCK1), which is 
involved in actin cytoskeleton organization and remodelling, decreased; this suggests a disconnection of the 
system. Inflammation of intestinal mucosa exacerbated molecular changes, being COL6A1, and TNC 
increased, whereas FAK decreased and ROCK1 increased, together with vimentin. Inflammation induces 
further cytoskeletal and ECM remodelling, which might have an impact on membrane mechanical properties. 
Concerning detyrosinated α-tubulin and vinculin, these molecules were decreased similarly to non-inflamed 
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IBD tissue, suggesting that these molecules are not targeted by inflammation and their expression changes 
are primary features of the IBD epithelial layer. To support the differential expression of proteins involved 
in signal mechanotransduction from outside to inside in inflamed tissues, and to determine whether 
lymphocytes’ homing induced by inflammation can be associated to ECM and cytoskeletal protein 
dysregulation, integrin β7 and α4, known to interact with the endothelial VCAM1 proteins [31, 32], were 
analysed by immunoblotting in colonic endoscopic biopsies. Results indicated that integrin β7 and α4 were 
unchanged in QUC vs C, whereas they increased in IUC vs C, confirming the specific role of these 
molecules in inflammation [33].  
Conversely (Figure 3 panel C and D), colonic endoscopic biopsies from QCD patients vs controls were 
characterized by normal levels of COL6A1 and integrin α4, whereas TNC, integrin β7, detyrosinated α-
tubulin, vinculin, FAK and ROCK1 were decreased and vimentin was increased. In ICD vs controls, an 
increase of COL6A1, vimentin and integrin α4 was observed, whereas FAK, TNC, vinculin and 
detyrosinated α-tubulin remained down-regulated, and ROCK1 and integrin β7 remained unchanged. 
Overall, these data suggest the inability of epithelial cells to reorganize their structure under inflammatory 
conditions. These results also indicate that the response of ICD patients is at variance compared to IUC 
patients. In particular, what appears peculiar is the absence of signal response from outside to inside 
epithelia and, in this context, the increase of COL6A1 could be associated to integrin overexpression. 
Furthermore, the increase of vimentin is not related to inflammation response, but could be associated to the 
transformation of interstitial sub-epithelial fibroblasts into myofibroblasts contributing to fibrosis [34-36]. 
Further experiments are required to clearly demonstrate this hypothesis. Collectively, these results indicate 
that substantial differences in the molecules involved in epithelial molecular homeostasis and in 
inflammatory response are present between UC and CD. 
3.2.2 Metabolism 
Proteomic results indicate dysregulation of enzymes involved in fatty acid oxidation (ACADSB and 
HSD17B10) and a decrease in two enzymes of oxidative phosphorylation (SDHA and ATP5B) in QUC vs C. 
QCD patients were characterized by an increase in GPD2, PDHB, NDUFS3 and ALDH9A1, whereas DLD 
enzyme appeared lower, suggesting that a metabolic rewiring could be adopted by the epithelial cell to 
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sustain energy demand, involving polyamine synthesis finalized to citrate homeostasis maintenance. 
According to the alteration of mechanotransduction signalling and to enzymes involved in oxidative energy 
production, the authors question whether citrate and fatty acids could be at variance, together with some 
upstream regulators, of the energy balance. Figure 4 shows citrate synthase, fatty acid synthase (FASN), 
peroxisome proliferator-activated receptors gamma (pparγ) and alpha (pparα) assessed by antigen antibody 
reaction in QUC, IUC, QCD and ICD vs controls.  
UC is characterized by an unchanged level of citrate synthase in non-inflamed patients, but this enzyme is 
decreased in IUC. Conversely, FASN, pparγ and pparα were down-regulated both in QUC and IUC [37], 
suggesting a lipid synthesis and oxidation impairment not supported by alternative metabolic pathways. 
Whereas the reduced expression/activation of pparγ in UC has been repeatedly demonstrated, data on pparα 
appear at variance compared to recent results by Zhou X. et al., Nature Communication 2014, in chronic 
dextran sulphate sodium (DSS)-induced colitis mouse model, in which the genes involved in PPARα-UGTs 
signalling were increased. Further experiments will be required to precisely clarify this discrepancy between 
DSS-induced colitis mice and UC patients [38].  
Concerning CD, decreased citrate levels could be associated to the dysregulation of specific metabolic 
enzymes, revealed by proteomics, suggesting a metabolic rewiring to compensate energy deficiency due to a 
decrement of lipid synthesis and oxidation characterizing non-inflamed epithelial CD cells. Under 
inflammation in CD, the citrate synthase levels were normalized, whereas pparγ increased. These results in 
QCD patients suggested a metabolic dysregulation at the alpha ketoglutarate metabolic node, which can 
induce a metabolic flux deviation toward polyamine and carnitine biosynthesis to refuel energy [39, 40].  
3.2.3 Autophagy in UC and CD 
Proteomic results indicate dysregulation of MYH9 and MVP proteins (for the first time described in IBDs), 
in both diseases and decrement of HSC70 and annexin 4 and 5 in QCD. Figure 5 shows levels of HSC70, 
MYH9 and MVP, respectively, in QUC and IUC compared to controls (panel A) and QCD and ICD 
compared to controls (panel B). The results indicate that HSC70 was unchanged in QUC while it increased 
in IUC. This result in UC cell extracts further supports the ability of these cells to activate the chaperone-
mediated autophagy. MYH9 only increased in QUC, while MVP increased in both QUC and IUC. 
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Conversely, the MYH9 and MVP proteins were reduced in QCD and ICD, while HSC70 was down-
regulated in QCD and it remained unchanged in ICD, thus confirming the proteomic results. Collectively, 
these data suggest that, due to their involvement in cellular homeostasis, these proteins can influence the 
autophagic process. The role of MYH9 has been recently associated to cell renewal following the axis 
Myh9-Rac1-PAK1-Akt pathway in the maintenance of Lgr5+ stem cells in DSS induced colitis [41]. The 
same protein has also been recently associated to p62 levels [42].  
Figure 5 panel D shows that p62 levels were increased in QUC and IUC compared to controls.   
Conversely, p62 levels were decreased in QCD and were increased in ICD (Figure 5, panel F), even though 
in ICD the down regulation of LC3, of MYH9 and MVP indicates that, despite inflammation, rescue 
processes for eliminating damaged material are not efficiently activated.  
To further clarify the nature of the autophagic process (macroautophagy vs chaperone-mediated autophagy) 
other molecules known to be involved in the autophagic flux regulation were assessed by immunoblotting. 
Autophagic flux was estimated by the autolysosome formation through LC3-II increase and p62 protein 
degradation or chaperone-mediated autophagy was assessed by the increase of the HSC70. Besides this, the 
molecules involved in autophagy activation/inhibition, such as BAX, beclin-1, Bcl-xL and BNIP3 were also 
considered. QUC was characterized by a decrease of BAX and BNIP3 and an increase of Beclin-1 and Bcl-
xL, whereas Bcl2 was decreased though not enough to reach statistical significance. In IUC, the pattern is 
characterized by an increase in Bcl-xL and BNIP3 and a decrease in Bcl2.  
Conversely, in QCD no changes were observed in BAX, Beclin-1 and Bcl2, whereas Bcl-xL was increased 
and BNIP 3 was decreased. ICD were characterized by increments of BAX, Bcl-xL and Bcl2, and a 
decreased of BNIP3, whereas Beclin-1 was unchanged [43].   
4 Discussion 
The unbiased differential proteomic approaches adopted in the present study provide evidence of several 
dysregulated molecules that characterise QUC and QCD epithelial cells. Collectively, these data suggest that 
ECM, mechanotransduction, metabolic rewiring and autophagy appear to be crucial nodes highlighting 
discrepancies and similarities in UC and CD at the molecular level and they may help shed light onto the 
physiopathological mechanisms characterizing these two disorders. It is worth noting that some results 
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provided by this study have also been previously observed, both at genetic and protein level; while others 
are original and support the use of a global proteomic approach to investigate physiopathological 
mechanisms of a disease [13-17]. The major pitfall of this study is represented by the restricted number of 
samples analysed and the small, but still present, degree of contamination in our IEC preparation. Despite 
this, a rigorous methodological approach of analysis was used, since only proteins being differentially 
expressed in all samples were considered and, in the case of ICPL methodology, only proteins recognized by 
5 peptides and with the same trend in all samples were taken into consideration. Finally, the validation step 
by antigen antibody reactions, in an independent set of samples and on mucosal biopsies was quite extensive, 
involving results from proteomic analyses and markers of upstream regulating pathways.  
Given that, QUC vs C were characterized by a cytoskeletal rearrangement in which keratin 8 (which was 
recently described as an autoantigen in rheumatoid arthritis [27]) is decreased, whereas other keratins 
(KRT10, KRT14, KRT18, KRT19) are increased, thus suggesting a structural re-arrangement at the 
epithelial level. The latter can account for several pieces of evidence, indicating that physical modifications 
of the epithelial layers, leading to an impaired permeability and cell renewal, have a prominent role in UC 
pathogenesis [44, 45].  
Indeed, IEC structural alterations parallel characteristic shifts in cell metabolic activity; in fact, in QUC vs 
controls, a decrease in enzymes of the TCA cycle and oxidative phosphorylation (succinate dehydrogenase 
and ATP synthase subunit beta), ACADSB, FASN, pparα and pparγ was observed, suggesting a down-
regulation of oxidative metabolism and fatty acid synthesis. Unexpectedly, the proteomic analysis 
highlighted the increase of a specific mitochondrial enzyme involved in isoleucine catabolism, with activity 
towards the degradation of short branched-chain fatty acids (HSD17B10). This amino acid is both 
glucogenic and ketogenic, and under starvation, the reduced carbon skeleton is used for energy production. 
This metabolic route to produce acetyl-CoA is typical of QUC patients and could be adopted by cells to 
support energy requirements and promote the activation of mTOR signalling (see Supporting Information 
Figure 4S). On the other hand, GWAS data [5] are supportive of our results, indicating the role of the ULK1 
gene in IBD. ULK1 is a tight regulator of TORC1/AMPK signalling pathway to sustain intracellular energy 
and nutrient levels in IBD counteracting starvation [9].Interestingly, in 1980, the hypothesis that UC may 
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originate from a defect of fatty acid (n-butyrate) oxidation of IEC was first proposed [46]; along the same 
lines, topical treatment with butyrate enemas showed some efficacy in distal UC [47, 48]. The increase in 
HSD17B10 can suggest an adaptation of the epithelial cell to counteract energy deficiency. Furthermore, 
HSD17B10 is also essential for intracellular steroid metabolism, and altered HSD17B10 enzyme level levels 
may cause a dysregulation in steroid pathways affecting the inﬂammatory response of colonic mucosa [28].  
The ECM components, such as COL6A1 and TNC, are involved in the integrity of the epithelial barrier and 
can influence outside to inside signalling, thus contributing to the lymphocytes homing. In this context, 
COLVI can promote the formation of the characteristic beaded microfilaments network in the ECM and act 
as a structural support and binding partner for other ECM proteins. Furthermore, it is involved in the 
inhibition of apoptosis and oxidative damage [49]. COL6A1 is a sensor of TGF-β signalling [50, 51] and 
vinculin is the cross-talk between ECM and actin cytoskeleton for the mature focal adhesion assembly [52, 
53]. FAK are necessary for the regulation of mechano-sensory activity of focal adhesions, and the small 
GTPase RhoA links the actin polymerisation at focal adhesions to the global actin dynamics [54]; FAK 
activation leads to the recruitment of PI3 kinase to focal adhesion, activating AKT. ROCK1 is a major 
downstream effector of RhoA and it is a regulator of the actomyosin cytoskeleton, influencing cell 
morphology, cell–cell and cell–matrix adhesion [55]. All these molecules are involved in the regulation of 
matrix stiffness. The latter influences cell migration, proliferation and survival [56, 57], and focal adhesions 
can form and grow only if they experience pulling forces through their cytoskeleton. It is known that growth 
on soft substrates leads to smaller focal adhesions, containing less phosphotyrosine and reduced cytoskeletal 
organisation [58]. In QUC, molecules associated to the cytoskeletal stiffness, such as vinculin and 
detyrosinated α-tubulin, are decreased, suggesting that the mechanical properties of the epithelial barrier are 
changed and the stiffness reduced [53, 59]. This reduction, described for the first time in QUC patients, 
could account also for an impaired cell renewal due to alteration of the mechanical properties of the tissue 
[57]. Further studies, specifically conducted on primary cultures are in progress and are aimed at precisely 
deciphering the role of membrane stiffness in invasion and cell renewal in IBDs. Interestingly, FAK and 
vimentin increased, whereas ROCK1, which is involved in actin cytoskeleton organization and remodelling, 
decreased, thus supporting the hypothesis of a decreased stiffness in QUC patients. Inflammation of the 
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mucosa exacerbated both molecular changes, as pinpointed by the increase in COL6A1, TNC, ROCK1, 
vimentin and lymphocyte homing to intestinal mucosa, which was indicated by increased integrin β7 and α4 
levels; on the contrary, decreased levels of FAK were observed. Concerning detyrosinated α-tubulin and 
vinculin, these molecules were not affected by the inflammatory process; their expression remained low, 
further suggesting the presence of constitutive alterations of the epithelial structure in UC. Indeed, changes 
in the epithelial barrier integrity may impact the autophagic process to eliminate damaged protein and 
organelles, and possible infiltrating bacteria. However, QUC patients are characterized by the activation of 
chaperone-mediated autophagy and macroautophagy. This conclusion is supported by many evidences at the 
molecular level, such as the metabolic stimulation of mTOR, thanks to increased isoleucine production, the 
activation of TORC promoting cell survival, the unchanged levels of HSC70, the increased levels of p62, 
MYH9 and MVP. All these molecules act in synergy and are harmonically regulated to sustain this process. 
In fact, the increase of beclin-1 was paralleled by the inhibitory action of Bcl-xL. Furthermore, 
LC3BII/LC3BI was down-regulated, indicating that LC3BI is not converted to LC3BII through lipidation. 
Collectively, these results suggest that the chaperone-mediated autophagy was not active and the cell 
adopted macroautophagy to eliminate waste material. Under inflammation, MVP, p62 and Bcl-xl remained 
up-regulated this indicates that macroautophagy is a characteristic trait of UC patients. 
Given the role of autophagy in alleviating ER stress and in regulating immune response, further support to 
this process is provided by COPA. COPA is able to promote the binding of proteins targeted for retrograde 
Golgi to ER transport and its increase can counteract ER stress and upregulation of Th17 priming cytokines 
in QUC patients. Interestingly, it has been recently described that gene mutations are associated to arthritis 
and to the COPA syndrome [60]. 
At variance, a different picture characterized QCD, Keratin 8 and 18 were decreased, leading to increased 
sensitivity of the epithelium to stress conditions and to TNF-mediated apoptosis [45]. COL6A1 increased in 
ICD only, while TNC decreased, together with detyrosinated α-tubulin and vinculin, both in quiescent and 
inflamed CD, indicating that the latter are structural variations that are not influenced by the inflammatory 
process and are typical traits of IBDs. However, the decrease of TNC combined with vinculin and 
detyrosinated α-tubulin have an impact on signalling inside the cell, thus inhibiting FAK and ROCK1 
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expression in QCD and hindering cell adhesion and actin filament assembly. Also in this case, the signalling 
is influenced by an increase in TGF-β and inflammation, which stimulate collagen VI expression, but it is 
unable to rescue FAK and ROCK 1 signalling. Collectively, these data suggest that some rescue 
mechanisms of mechanical membrane integrity are blunted in QCD patients, leaving them more exposed to 
bacterial invasion. Furthermore, because vimentin increased both in QCD and ICD, it could be associated to 
interstitial sub-epithelial fibroblasts-to-myofibroblasts transition and therefore contribute to fibrotic 
structures generation [34-36], which is a common complication of CD. To support this hypothesis, further 
experiments adopting primary cell cultures will be required.  
Metabolic rewiring is another point characterising QCD, when it is finalised to sustain energy demand 
involving polyamine synthesis and citrate homeostasis maintenance. Furthermore, the increase in ERLIN2, 
which mediates the endoplasmic reticulum-associated degradation (ERAD) of inositol 1,4,5-trisphosphate 
receptors (IP3Rs) [61, 62] and of sterol-accelerated of HMGCR [63], indicates that the deregulation of 
cellular cholesterol homeostasis may promote ER retention of the SCAP-SREBP complex [64-66], thus 
highlighting the role of changes in cholesterol homeostasis in CD. Such changes have never been described 
before: interestingly, they may account for alterations of cell membrane, ER and Golgi apparatus' structure 
in IEC from CD.  
Furthermore, the disease appears to be characterized by ER stress and UPR, since GRP78, GRP58, and 
PRDX2 are reduced.  
Autophagic impairment represents another critical point in CD. This impairment has already been suggested, 
since ATG genes polymorphysms have been identified in CD, though a detailed analysis at molecular level 
in patients is still lacking. Proteomics indicate a decrease in HSC70, which is a key factor regulating 
chaperone-mediated autophagy. This decrease implies the absence of the chaperone-mediated autophagy, 
which is an important process for the clearance of damaged cells and organelles. The analysis of 
AKT/mTOR pathways, shown as supporting information in Figure 4S, combined with the decrease of p62, 
MYH9 and MVP, the inhibition of beclin-1 by Bcl-xL and the down regulation of LC3BII/LC3BI, indicates 
that both micro and macroautophagy are impaired and inflammation does not induce significant changes to 
overcome this issue. According to the present results, it can be concluded that, not only autophagy is 
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impaired in CD but several processes involved in protein degradation are also blunted. To counteract this 
severe authophagic impairment associated with energy deficiency, it could be relevant, at least for QCD 
patients, to sustain citrate production through polyamines supplementation, which can possibly ameliorate 
the CD phenotype. 
In conclusion, this study shows that specific protein profiles are associated with UC and CD. The study also 
outlines the relevance of autophagy and epithelial cell integrity and identifies specific markers that are likely 
to characterise UC and CD in quiescent and inflammatory conditions. Furthermore, our study identifies the 
role of membrane stiffness in mechanotransduction signalling and its impact on cell death, metabolism and 
stress response. Finally, these results highlight the importance of unbiased proteomic approaches, which 
have been valuable tools in understanding the complex mechanisms associated to IBD. The authors hope 
these results help pave the way for more specific validations of dysregulated proteins in larger cohorts.  
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Legends 
Figure 1. Proteomic analysis by 2D-DIGE. Histograms of differentially expressed proteins observed by 2D-
DIGE in non-inflamed UC (QUC) and CD (QCD) versus controls (C). Two different comparisons were 
performed: QUC vs C (gray bars) and QCD vs C (black bars). Statistical analysis was performed using 
DeCyder EDA 1.0 module; independent one-way ANOVA coupled to Turkey’s multiple group comparison 
test (P<0.01) were used to determine protein spots significantly different between the analyses. 
Differentially expressed proteins are indicated by their gene name and they are expressed as % of fold 
change. List of proteins differentially expressed in all comparisons were grouped according to their role 
together with statistical analysis and are presented as raw data sets in Supplementary Tables 2S. 
Cytoskeleton organization: KRT8, Keratin type II cytoskeletal 8; KRT18, Keratin type I cytoskeletal 18; 
KRT19, Keratin type I cytoskeletal 19; ACTB, Actin cytoplasmic 1; TUBB4B, Tubulin beta-2C chain; 
IMMT, Mitochondrial inner membrane protein. Metabolic proteins: GPD2, Glycerol-3-phosphate 
dehydrogenase mitochondrial; PDHB, Pyruvate dehydrogenase E1 component subunit beta mitochondrial 
precursor; DLD, Dihydrolipoyl dehydrogenase mitochondrial; SDHA, Succinate dehydrogenase 
[ubiquinone] flavoprotein subunit mitochondrial; NDUFS3, NADH dehydrogenase [ubiquinone] iron-sulfur 
protein 3 mitochondrial; ATP5B, ATP synthase subunit beta; ACADSB, Short/branched chain specific acyl-
CoA dehydrogenase mitochondrial; HSD17B10, 3-hydroxyacyl-CoA dehydrogenase type-2; ALDH9A1, 4-
trimethylaminobutyraldehyde dehydrogenase. Stress and antioxidant proteins: HSP60, 60 kDa heat shock 
protein mitochondrial; HSC70, Heat shock cognate 71 kDa protein; HSPA1A/B, Heat shock 70 kDa protein 
1A/1B; GRP78, 78 kDa glucose-regulated protein (GRP78); GRP58, Protein disulfide-isomerase A3; 
PRDX2, Peroxiredoxin-2. DNA synthesis: PHB, Prohibitin. RNA processing: LGALS3, Galectin-3. Protein 
biosynthesis: TUFM, Elongation factor tu mitochondrial. Transport proteins: VDAC1, Voltage-dependent 
anion-selective channel protein 1; MRPS22, 28S ribosomal protein S22 mitochondrial; ERLIN2, 
Endoplasmic reticulum lipid raft-associated protein 2. Others proteins: ANXA4, Annexin A4; ANXA5, 
Annexin A5; CA1, Carbonic anhydrase 1; RACK1, Receptor of activated protein C kinase 1; C1QBP, 
Complement component 1 Q subcomponent-binding protein, mitochondrial. 
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Figure 2. Proteomic analysis by Isotope-Coded Protein Labeling (ICPL). Histograms of differentially 
expressed proteins observed by ICPL in non-inflamed UC (QUC) and CD (QCD) versus controls (C). Two 
different comparisons were performed: QUC vs C (gray bars) and QCD vs C (black bars). Differentially 
expressed proteins are indicated by their gene name and they are expressed as % of fold change. List of 
proteins differentially expressed in all comparisons were grouped according to their role together with 
statistical analysis and are presented as raw data sets in Supplementary Tables 3S. Cytoskeleton 
organization: MYH9, Myosin-9; KRT10, Keratin type I cytoskeletal 10; KRT14, Keratin type I cytoskeletal 
14; KRT18, Keratin type I cytoskeletal 18; TUBA1B, Tubulin alpha-ubiquitous chain; VIM, Vimentin. 
Metabolic protein: HSD11B2, Corticosteroid 11-beta-dehydrogenase isozyme 2. RNA splicing and 
transport: HNRNPA1, Heterogeneous nuclear ribonucleoprotein A1; MVP, Major vault protein. Chromatin 
organization: HIST2H2AA3, Histone H2A type 2-A; HIST1H2AB, Histone H2A type 1-B; HIST1H2AC, 
Histone H2A type 1-C; HIST1H3A, Histone H3.1; HIST1H4A, Histone H4; SFPQ, Splicing factor proline- 
and glutamine-rich. Protein folding: TRAP1, Heat shock protein 75 kDa mitochondrial precursor; PPIB, 
Peptidyl-prolyl cis-trans isomerase B precursor. Transport proteins: RRBP1, Ribosome-binding protein 1; 
COPA, Coatomer subunit alpha; ATP1A1, Sodium/potassium-transporting ATPase alpha-1 chain precursor. 
Figure 3. Stiffness and mechanotransduction. Representative immunoblot images (A, C) and histograms 
(means ± SD; B, D) of proteins expression of collagen type VI Alpha 1 Chain (COL6A1), tenascin C (TNC), 
Integrin β7, Integrin α4, focal adhesion kinase (FAK), Rho-associated protein kinase 1 (ROCK1), Vinculin, 
detyrosinated α-Tubulin (de Tyr α-Tubulin) and Vimentin, in inflamed and quiescent ulcerative colitis (IUC, 
QUC) compared to controls (C), and in inflamed and quiescent Crohn’s Disease (ICD, QCD) compared to C. 
The data were normalized against the total amount of loaded proteins stained with Sypro Ruby. Statistical 
analysis was performed by Student’s t-test (p<0.05). * change compared to control; ‡ variation between 
QUC vs IUC and QCD vs ICD. 
Figure 4. Upstream regulators of fatty acid metabolism. Representative immunoblot images (A, C) and 
histograms (means ± SD; B, D) of proteins expression of citrate synthase, fatty acid synthase (FASN), 
peroxisome proliferator-activated receptors gamma (pparγ) and peroxisome proliferator-activated receptors 
alpha (pparα), in inflamed and quiescent ulcerative colitis (IUC, QUC) compared to controls (C), and in 
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inflamed and quiescent Crohn’s Disease (ICD, QCD) compared to C. The data were normalized against the 
total amount of loaded proteins stained with Sypro Ruby. Statistical analysis was performed by Student’s t-
test (p<0.05). * change compared to control; ‡ variation between QUC vs IUC and QCD vs ICD. 
Figure 5. Autophagy. Representative immunoblot images (C, E, G) and histograms (means ± SD; A, B, D, 
F) of proteins expression of Heat shock cognate 71 kDa protein (HSC70), myosin heavy chain 9 (MYH9), 
major vault protein (MVP), ubiquitin-binding protein p62 (p62), light chain 3B (LC3B), bcl-2-like protein 4 
(Bax), beclin1, B-cell lymphoma-extra large (Bcl-xL), BCL2/adenovirus E1B 19 kDa protein-interacting 
protein 3 (Bnip3) and B-cell leukemia/lymphoma 2 (Bcl-2), in inflamed and quiescent ulcerative colitis 
(IUC, QUC) compared to controls (C), and in inflamed and quiescent Crohn’s Disease (ICD, QCD) 
compared to C. The data were normalized against the total amount of loaded proteins stained with Sypro 
Ruby. Statistical analysis was performed by Student’s t-test (p<0.05). * change compared to control; ‡ 
variation between QUC vs IUC and QCD vs ICD. 
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